Related Experiment Video
Updated: Jul 12, 2025
Delivery of Therapeutic Agents Through Intracerebroventricular ICV and Intravenous IV Injection in Mice
Published on: October 3, 2011
Spinal Muscular Atrophy Type 1 Survival Without New Pharmacotherapies: Two Treatment Paradigms
John R Bach1, Louis Saporito, William Weiss
1From the Department of Physical Medicine and Rehabilitation, Rutgers University New Jersey Medical School, Newark, New Jersey (JRB, LS).
Insights
Continuous noninvasive ventilatory support and mechanical in-exsufflation offer effective respiratory management for infants with spinal muscular atrophy type 1. This approach significantly reduces the need for tracheotomies and improves long-term survival rates.
Area of Science:
- Pediatric Pulmonology
- Neuromuscular Disorders
- Respiratory Care
Background:
- Spinal muscular atrophy type 1 (SMA1) is a severe genetic disorder characterized by progressive muscle weakness and respiratory failure.
- Traditional management often involves invasive ventilation and tracheotomy, carrying significant risks and impacting quality of life.
Purpose of the Study:
- To evaluate the outcomes of noninvasive respiratory management using continuous noninvasive ventilatory support (CNVS) and mechanical in-exsufflation (MIE) in infants with SMA1.
- To assess the impact of these noninvasive methods on long-term survival and the need for invasive procedures.
- To consider the interplay between new medical therapies and noninvasive respiratory support in SMA1.
Main Methods:
- A retrospective review of consecutively referred symptomatic infants with SMA1 managed with CNVS and MIE from infancy.
- Monitoring of intubations, tracheotomies, and survival rates.
- Analysis of extubation success rates and duration of noninvasive support.
Main Results:
- Of 37 infants who became dependent on CNVS, 18 required it long-term (mean 18.6 years), surviving to a mean age of 25.3 years.
- An 85% extubation success rate per attempt (150/176) was achieved, with only one patient requiring a tracheotomy.
- Early medical treatments can modify SMA1 progression, but noninvasive support remains crucial for managing respiratory complications like pneumonia.
Conclusions:
- Noninvasive ventilatory support and mechanical in-exsufflation provide a viable and effective alternative to invasive ventilation for infants with SMA1.
- This management strategy significantly improves survival and reduces the need for tracheotomies, enhancing patient quality of life.
- The combination of early medical interventions and robust noninvasive respiratory support represents a paradigm shift in SMA1 care.
Objectives:
The aims of the study are to present noninvasive respiratory management outcomes using continuous noninvasive ventilatory support and mechanical in-exsufflation from infancy for spinal muscular atrophy type 1 and to consider bearing on new medical therapies.
Design:
Noninvasive ventilatory support was begun for consecutively referred symptomatic infants with spinal muscular atrophy type 1 from 1 to 10 mos of age. Intercurrent episodes of respiratory failure were managed by intubation then extubation to continuous noninvasive ventilatory support and mechanical in-exsufflation despite failing ventilator weaning and extubation attempts. Intubations, tracheotomies, and survival were monitored.
Results:
Of 153 patients with spinal muscular atrophy 1 consecutively referred since 1995, 37 became continuous noninvasive ventilatory support dependent, almost half before 10 yrs of age. Of the 37, 18 required continuous noninvasive ventilatory support for a mean 18.6 ± 3.3 yrs to a mean 25.3 (range, 18-30) yrs of age, dependent from as young as 4 mos of age with 0 to 40 ml of vital capacity. One of the 18 died from COVID-19 acute respiratory distress syndrome at age 24 after 23 yrs of continuous noninvasive ventilatory support. Extubation success rate of 85% per attempt (150/176) resulted in only one undergoing tracheotomy.
Conclusions:
Medical treatments begun during the first 6 wks of age convert spinal muscular atrophy 1 into spinal muscular atrophy 2 or 3 but cough flows remain inadequate to avoid many pneumonias that, once resolved by a treatment paradigm of extubation to continuous noninvasive ventilatory support and mechanical in-exsufflation, eliminates need to resort to tracheotomies.
Related Concept Videos
01:20Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
01:24Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
01:21Satellite Stem Cells and Muscular Dystrophy